← Back to Search

Intervention arm (single arm) for Cervical Cancer Screening (ACT NOW Trial)

N/A
Recruiting
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women ages 25 years to 65 years, with a cervix, presenting in the waiting areas at the Ben Taub General Hospital Emergency Department
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

ACT NOW Trial Summary

This trial aims to create and test a new method to increase cervical cancer screening among women who do not regularly get screened. Specifically, it will focus on women who do not have insurance or have limited insurance

Who is the study for?
This trial is for women who haven't been regularly screened for cervical cancer and often use emergency services as their primary healthcare, especially those without insurance or with insufficient coverage. They will be approached in the ER waiting rooms of a safety net hospital to participate.Check my eligibility
What is being tested?
The study is testing if offering HPV self-sampling kits to women in an emergency room setting can increase cervical cancer screening rates among those who typically do not attend regular screenings.See study design
What are the potential side effects?
Since this intervention involves only self-sampling for HPV, there are minimal side effects expected. Some participants might experience discomfort or emotional distress during the self-sampling process.

ACT NOW Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman aged 25-65 with a cervix, at Ben Taub Hospital's ER.

ACT NOW Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
HPV self-sampling completion
Secondary outcome measures
Attendance for cervical cancer screening among HR-HPV positive women
HPV self-sampling acceptability

ACT NOW Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention arm (single arm)Experimental Treatment1 Intervention
Intervention arm to complete HPV self-sampling

Find a Location

Who is running the clinical trial?

Baylor College of MedicineLead Sponsor
1,001 Previous Clinical Trials
6,002,312 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are potential participants currently able to apply for enrollment in this ongoing clinical trial?

"Indeed, the details on clinicaltrials.gov state that this ongoing clinical trial is actively seeking individuals to participate. The initial posting of this trial was made on November 15th, 2023 and it was last modified on December 20th, 2023. This particular study aims to enroll a total of 100 participants from a single designated site."

Answered by AI

Is the inclusion criteria for this medical study limited to individuals below 45 years of age?

"Prospective participants in this trial must be between the ages of 25 and 65. It is worth noting that there are a total of 50 clinical trials available for individuals under the age of 18, while there are 449 trials targeting patients over the age of 65."

Answered by AI

What are the specific criteria that determine if an individual is eligible to participate in this research study?

"To be eligible for inclusion in this clinical trial, candidates must meet the following criteria: undergo cervical cancer screening and fall within the age range of 25 to 65. This study aims to enroll a total of 100 participants."

Answered by AI

What is the upper limit on the number of individuals participating in this medical study?

"Indeed, the information available on clinicaltrials.gov indicates that this ongoing clinical trial is actively seeking eligible candidates. The study was initially posted on November 15th, 2023 and last updated on December 20th, 2023. The research team aims to recruit a total of 100 patients from a single designated site."

Answered by AI
~0 spots leftby May 2024